Gambacorta, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 7.564
EU - Europa 7.364
AS - Asia 3.471
SA - Sud America 670
AF - Africa 122
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 14
Totale 19.241
Nazione #
US - Stati Uniti d'America 7.460
DE - Germania 2.124
SE - Svezia 1.600
SG - Singapore 1.259
IT - Italia 1.148
CN - Cina 1.067
BR - Brasile 621
FR - Francia 477
IN - India 450
IE - Irlanda 446
UA - Ucraina 348
GB - Regno Unito 285
ID - Indonesia 271
FI - Finlandia 227
RU - Federazione Russa 162
PL - Polonia 124
BE - Belgio 95
TR - Turchia 79
CA - Canada 66
KR - Corea 65
CI - Costa d'Avorio 64
AT - Austria 58
NL - Olanda 57
CZ - Repubblica Ceca 52
HK - Hong Kong 52
IR - Iran 28
JP - Giappone 28
AU - Australia 25
LT - Lituania 24
CH - Svizzera 22
PK - Pakistan 21
PH - Filippine 19
ES - Italia 18
RO - Romania 18
MX - Messico 17
PE - Perù 17
IL - Israele 14
VN - Vietnam 14
DZ - Algeria 11
EG - Egitto 11
GR - Grecia 11
IQ - Iraq 11
MA - Marocco 11
NZ - Nuova Zelanda 11
PA - Panama 10
AE - Emirati Arabi Uniti 9
BD - Bangladesh 9
EC - Ecuador 9
AM - Armenia 8
AR - Argentina 8
AZ - Azerbaigian 8
BG - Bulgaria 8
DK - Danimarca 8
ZA - Sudafrica 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AL - Albania 7
EU - Europa 7
KG - Kirghizistan 7
NO - Norvegia 7
UZ - Uzbekistan 7
RS - Serbia 6
CL - Cile 5
KZ - Kazakistan 5
LK - Sri Lanka 5
PT - Portogallo 5
SA - Arabia Saudita 5
BH - Bahrain 4
KE - Kenya 4
MT - Malta 4
SC - Seychelles 4
TW - Taiwan 4
CO - Colombia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
JM - Giamaica 3
LU - Lussemburgo 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BO - Bolivia 2
CR - Costa Rica 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
JO - Giordania 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
VE - Venezuela 2
BY - Bielorussia 1
CD - Congo 1
ET - Etiopia 1
GT - Guatemala 1
IM - Isola di Man 1
Totale 19.229
Città #
Chandler 1.788
Singapore 825
Ashburn 565
Dublin 444
New York 300
Ann Arbor 273
Jakarta 257
Jacksonville 249
Hyderabad 246
San Mateo 245
Rome 236
Milan 214
The Dalles 175
Wilmington 170
Princeton 146
Nanjing 139
Boston 132
Nürnberg 131
Beijing 125
Los Angeles 121
Helsinki 117
Marseille 117
Moscow 117
Bremen 114
Cattolica 113
Dearborn 109
Munich 102
Woodbridge 102
Fairfield 96
Warsaw 93
Houston 91
Brussels 89
Hefei 83
Frankfurt am Main 82
Redwood City 82
Seattle 66
Lawrence 65
Abidjan 64
Seoul 64
Izmir 52
Nanchang 50
Düsseldorf 48
Leawood 47
São Paulo 45
Nuremberg 44
Boardman 42
Chicago 42
London 42
Washington 41
Zhengzhou 41
Hong Kong 40
Shenyang 39
Brno 35
North Bergen 35
Vienna 34
Augusta 32
Detroit 32
Falls Church 30
Norwalk 30
Pune 28
Hebei 27
Toronto 27
Kunming 26
Columbus 25
Lauterbourg 25
Ottawa 25
Falkenstein 24
Turku 24
Jiaxing 23
Paris 22
Fremont 21
Guangzhou 21
Hangzhou 21
Cambridge 20
Shanghai 20
Lancaster 19
Mountain View 19
Phoenixville 19
Tianjin 19
Brooklyn 17
Lima 17
University Park 17
Belo Horizonte 16
Phoenix 16
Redmond 16
San Diego 16
Andover 15
Changsha 15
Kraków 15
Santa Clara 15
Kish 14
Ningbo 14
Portsmouth 14
Atlanta 13
Chengdu 13
Amsterdam 12
Jinan 12
Lappeenranta 12
Rio de Janeiro 12
San Francisco 12
Totale 10.106
Nome #
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 320
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 229
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 203
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 184
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 175
Multimodality treatment of unresectable stage III non small cell lung cancer: interim analysis of a phase II trial using preoperative gemcitabine with concurrent radiotherapy 174
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 174
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 173
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 173
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 172
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 171
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 154
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 152
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 150
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 147
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 145
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 143
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 143
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 142
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 137
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 134
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial. 134
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 133
Lung recruitment strategies and surfactant in neonatal intensive care unit 133
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 132
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 130
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 130
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 126
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 126
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 125
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 125
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 123
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 120
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 118
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 118
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 115
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 111
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 107
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 106
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 106
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 105
Virtual simulation:fifteen years later 104
An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine 104
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 101
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 101
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 101
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 100
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 100
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 99
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 98
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 97
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 97
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum 96
Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: A multicentric prospective study with external validation. 96
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 96
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 95
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 95
IGRT in rectal cancer. 94
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 94
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 94
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 93
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 93
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 93
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 93
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 92
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 92
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 91
Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications 90
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 90
The assisi think tank meeting breast large database for standardized data collection in breast cancer—attm.Blade 89
The INTER-ROMA project--a survey among Italian radiation oncologists on their approach to the treatment of bone metastases 87
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 87
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 87
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 86
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 86
Postoperative 5-FU based radiochemotherapy in rectal cancer: retrospective long term results and prognostic factors of a pooled analysis on 1,338 patients 85
Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: Analysis on 1798 patients by prediction model 85
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 84
Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer 84
Could the surgeon trust to radiotherapy help in rectal cancer? 81
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 80
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 80
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 79
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 79
A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer 79
A radiotherapy staff experience of gratitude during COVID-19 pandemic 79
The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. 78
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer 76
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 76
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 75
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 75
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 75
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 75
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 75
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 75
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 74
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 74
The Safety of Radiotherapy in the Treatment of Primary Cutaneous B-Cell Lymphoma: A Multidisciplinary Systematic Review 74
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 74
Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. 73
Totale 11.173
Categoria #
all - tutte 97.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020362 0 0 0 0 0 0 0 0 0 0 265 97
2020/20211.094 85 102 28 109 169 52 111 31 128 68 162 49
2021/20222.024 181 77 35 166 86 72 32 268 133 143 446 385
2022/20234.982 649 651 372 773 278 591 261 395 587 153 194 78
2023/20242.659 108 690 127 186 130 462 164 94 31 97 280 290
2024/20254.807 113 150 422 220 594 233 238 231 772 712 1.122 0
Totale 19.601